Testing wearable sensors to measure movement in Spinocerebellar Ataxia
Wearable Sensors for Quantitation of Impaired Gait and Balance
This study tests if wearable sensors can help track movement in people with Spinocerebellar Ataxia to better understand their condition.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 600 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Sponsor | University of Chicago Academic / other |
| Locations | 1 site (Chicago, Illinois) |
| Trial ID | NCT06628934 on ClinicalTrials.gov |
What this trial studies
This research involves using body-worn sensors to assess movement during coordination tests in individuals with Spinocerebellar Ataxia (SCA). Participants will undergo a neurological examination using the iSARA exam and complete three questionnaires to evaluate their condition. The study aims to gather data on the progression and severity of SCA through these measurements. Participation is expected to take about one hour.
Who should consider this trial
Good fit: Ideal candidates include individuals with a genetic confirmation of SCA and healthy controls who can sit or stand unassisted.
Not a fit: Patients with other neurological or musculoskeletal disorders affecting balance, gait, or voluntary movement may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved methods for monitoring and understanding the progression of Spinocerebellar Ataxia.
How similar studies have performed: While the use of wearable sensors in movement assessment is gaining traction, this specific application in Spinocerebellar Ataxia is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Ataxia Group - Individuals who have a genetic-confirmation of SCA diagnosis and are able to sit or stand unassisted for 30 seconds and follow directions. * Healthy Control Group - Individuals who are able to sit or stand unassisted for 30 seconds and follow directions. Exclusion Criteria: * Any other neurological or musculoskeletal disorder not attributed to the SCA that could affect balance, gait or voluntary movement.
Where this trial is running
Chicago, Illinois
- University of Chicago — Chicago, Illinois, United States (Recruiting)
Study contacts
- Study coordinator: Hannah Casey
- Email: hannahcasey@uchicago.edu
- Phone: 773-702-4610
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.